Regulatory Issues
ACR® is committed to representing and communicating radiologists’ perspectives to the executive branch of the U.S. government.
Federal regulatory and research agencies can have a profound impact on radiology practice and the future of medicine. ACR is committed to representing and communicating radiologists’ perspectives to policymakers, regulators and other agency staff throughout the executive branch of the U.S. government.
Information Blocking
The Information Blocking provision discourages interference by relevant providers, developers and networks of legally permissible access, exchange and use of electronic health information. Learn more
Artificial Intelligence and Digital Health
ACR advocates radiology’s perspective to the federal government with respect to artificial intelligence (AI) and digital health policy issues, including advocating for AI safety and effectiveness, technology innovation and data sharing.
AI Safety, Effectiveness and Quality Use
- ACR Comments to FDA on CAD Petition (Feb. 24, 2026)
- ACR Response to HHS RFI on Clinical AI Policy (Feb.23, 2026)
- ACR Comments to FDA on Postmarket Evaluation of AI Devices (Dec. 1, 2025)
- ACR response to OSTP RFI on AI regulatory reforms (Oct. 27, 2025)
- ACR comments to NIST on Proposed AI Standard (Sept. 12, 2025)
- ACR comments to FDA on AI Draft Guidance (April 7, 2025)
- ACR informs White House AI Action Plan (March 14, 2025)
- ACR testimony to FDA DHAC on GenAI oversight (Jan. 21, 2025)
- ACR comments to Congress in response to a Cures 2.0 RFI (Aug. 2, 2024)
- ACR comments to Congress regarding the state of AI in healthcare (May 6, 2024)
- ACR comments to Senate HELP Minority AI White Paper and RFC (Sept. 22, 2023)
- ACR comments on FDA Draft Guidance: AI Predetermined Change Control Plans (July 31, 2023)
- ACR comments on FDA Draft Guidance: Breakthrough Devices Program (Dec. 15, 2022)
- ACR comments on HHS OCR-CMS NPRM: Algorithm Use Nondiscrimination, ACA Sec. 1557 (Sept. 28, 2022)
Loading component...
Radiation Safety and Medical Use
ACR advocates radiology’s perspective to the federal government on medical radiation safety issues, such radiological materials licensing, authorized use, and drug/device oversight and availability to patients.
Loading component...
Loading component...
Loading component...
Loading component...
Public Health and Population Screening
ACR advocates radiology’s perspective to the federal government concerning radiology related public health concerns, including population screening, guidelines and programs.
Loading component...
For older public record documents from ACR to federal agencies please refer to regulations.gov, or contact Michael Peters, Senior Director, Government Affairs, or Katie Grady, Government Affairs Director.
